Avançsa, the Catalan public enterprise agency for industrial promotion and location, attached to the Department of Business and Labour (Departament d’Empresa i Treball), has invested €1.5 million in medical technology company Aortyx, acquiring a 7.5% stake in its share capital (7.52% according to the final transaction structure).
The operation was authorised by the Catalan Government’s Executive Council (Consell Executiu) and forms part of Avançsa’s strategy to support high-impact technological and healthcare projects through public-private collaboration.
Strengthening a funding round exceeding €15 million
With this capital injection, Avançsa joins Aortyx’s Series A financing round, which now exceeds €15 million following the public holding’s investment. The company had previously closed a €13.8 million round in June 2025, led by Ship2B Ventures and Clave Capital through the BSocial Impact Fund and Clave Innohealth funds.
The additional funding will enable Aortyx to advance the development and clinical validation of its bioabsorbable patch for the treatment of aortic tears, an innovative solution for a severe vascular condition. The company does not expect the product to reach the market until 2029.
A technology for the treatment of aortic dissection
Aortyx, based in Esplugues de Llobregat and founded in 2018, is specialised in the development of next-generation medical devices for the treatment of vascular diseases, with a particular focus on aortic dissection.
This condition is characterised by a tear in the inner layer of the aorta and the formation of a false channel that can compromise blood flow and lead to potentially fatal consequences. The company currently employs 20 professionals and focuses on developing bioabsorbable solutions aimed at improving the treatment of these diseases.
Boosting public-private collaboration in healthcare innovation
Avançsa’s participation is part of its “Extraordinary Projects Line” and aims to help transfer knowledge generated in Catalan research centres into the productive sector, while supporting business initiatives with a clear healthcare impact.
The investment also highlights the importance of public-private collaboration in enabling high value-added innovations to reach the market, within a broader context of participation by state and European institutions in this growth phase.
Avançsa, a public instrument for business development
Avançsa is a public entity fully owned by the Government of Catalonia and attached to the Department of Business and Labour. Its mission is to strengthen the Catalan business ecosystem through public-private collaboration, supporting industrial reactivation and promoting innovative, high-value-added projects that contribute to sustainability and quality employment.
With this investment, the agency reinforces its commitment to supporting emerging technology companies with strong potential to transform the healthcare and biotechnology sectors.
cloud technology axon
SEG is an independent manufacturer of medium-voltage protection relays...
